Decellularization of bovine pericardium for tissue-engineering by targeted removal of xenoantigens

Journal of Heart Valve Disease

Volumn 14, Issue 2, 2005, Pages 212-217

  Gonçalves, Ana C ^a   Griffiths, Leigh G ^a   Anthony, Russell V ^a   Orton, E Christopher ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSIDASE; ALPHA SMOOTH MUSCLE ACTIN; ANTIGEN; DEOXYRIBONUCLEASE; DODECYL SULFATE SODIUM; GALACTOSE ALPHA1,3 GALACTOSE; HETEROANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PHOSPHOLIPASE A2; RIBONUCLEASE; TRITON X 100; UNCLASSIFIED DRUG; ACTIN; DISACCHARIDE; EPITOPE; GALACTOSYL (1 3)GALACTOSE; GALACTOSYL-(1-3)GALACTOSE; HETEROPHILE ANTIGEN; HLA ANTIGEN CLASS 1;

ANIMAL TISSUE; ANTIGENICITY; ARTICLE; CONTROLLED STUDY; COW; IMMUNOHISTOCHEMISTRY; LYSIS; MICROSCOPY; NONHUMAN; PERICARDIUM; PRIORITY JOURNAL; TEMPERATURE MEASUREMENT; TISSUE ENGINEERING; WESTERN BLOTTING; XENOGRAFT; ANIMAL; CATTLE; CYTOLOGY; ISOLATION AND PURIFICATION; METHODOLOGY;

ACTINS; ANIMALS; ANTIGENS, HETEROPHILE; CATTLE; CYTOLOGICAL TECHNIQUES; DISACCHARIDES; EPITOPES; HISTOCOMPATIBILITY ANTIGENS CLASS I; PERICARDIUM; TISSUE ENGINEERING;

EID: 24344463945     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Elkins RC. Tissue-engineered valves. Ann Thorac Surg 2002;74:1434
2. Mayer JE, Jr. In search of the ideal valve replacement device. J Thorac Cardiovasc Surg 2001;122:8-9
3. Bader A, Schillin T, Teebken OE, et al. Tissue engineering of heart valves - human endothelial cell seeding of detergent acellularized porcine valves. Eur J Cardiothorac Surg 1998;14:279-284
4. Schenke-Layland K, Vasilevski O, Opitz F, et al. Impact of decellularization of xenogeneic tissue on extracellular matrix integrity for tissue engineering of heart valves. J Struct Biol 2003;143:201-208
5. Courtman DW, Pereira CA, Kashef V, McComb D, Lee JM, Wilson GJ. Development of a pericardial acellular matrix biomaterial: Biochemical and mechanical effects of cell extraction. J Biomed Mater Res 1994;28:655-666
6. Courtman DW, Pereira CA, Omar S, Landgdon SE, Lee JM, Wilson GJ. Biomechanical and ultrastructural comparison of cryopreservation and a novel cellular extraction of porcine aortic valve leaflets. J Biomed Mater Res 1995;29:1507-1516
7. Booth C, Korossis SA, Wilcox HE, et al. Tissue engineering of cardiac valve prostheses I: Development and histological characterization of an acellular porcine scaffold. J Heart Valve Dis 2002;11:457-462
8. Kasimir MT, Rieder E, Seebacher G, et al. Comparison of different decellularization procedures of porcine heart valves. Int J Artif Organs 2003;26:421-427
9. O'Brien MF, Goldstein S, Walsh S, Black KS, Elkins R, Clarke D. The SynerGraft valve: A new acellular (nonglutaraldehyde-fixed) tissue heart valve for autologous recellularization first experimental studies before clinical implantation. Semin Thorac Cardiovasc Surg 1999;11(Suppl.1):194-200
10. Piatt JL. The immunological hurdles to cardiac xenotransplantation. J Card Surg 2001;16:439-447
11. Igaz P. Recent strategies to overcome the hyperacute rejection in pig to human xenotransplantation. Yale J Biol Med 2001;74:329-340
12. Galili U, Shohet SB, Kobrin E, Stults CL, Macher BA. Man, apes, and Old World monkeys differ from other mammals in the expression of alpha-galactosyl epitopes on nucleated cells. J Biol Chem 1988;263:17755-17762
13. Thall A, Galili U. Distribution of Galα1α3Galα1α 4GlcNAc residues on secreted mammalian glycoproteins (thyroglobulin, fibrinogen, and immunoglobulin G) as measured by a sensitive solid-phase radioimmunoassay. Biochemistry 1990;29:3959-3965
14. Galili U, Rachmilewitz EA, Peleg A, Flechner I. A unique natural human IgG antibody with anti-alpha-galactosyl specificity. J Exp Med 1984;160:1519-1531
15. Goldstein S, Clarke DR, Walsh SP, Black KS, O'Brien MF. Transpecies heart valve transplant: Advanced studies of a bioengineered xeno-autograft. Ann Thorac Surg 2000;70:1962-1969
16. Elkins RC, Goldstein S, Hewitt CW, et al. Recellularization of heart valve grafts by a process of adaptive remodeling. Semin Thorac Cardiovasc Surg 2001;13(Suppl.1):87-92
17. Simon P, Kasimir MT, Seebacher G, et al. Early failure of the tissue engineered porcine heart valve SYNERGRAFT in pediatric patients. Eur J Cardiothorac Surg 2003;23:1002-1006
18. Hoerstrup SP, Sodian R, Daebritz S, et al. Functional living trileaflet heart valves grown in vitro. Circulation 2000;102:III-44-III-49
19. Shinoka T, Breuer CK, Tanel RE, et al. Tissue engineering heart valves: Valve leaflet replacement study in a lamb model. Ann Thorac Surg 1995;60:S513-S516
20. Shinoka T, Shum-Tim D, Ma PX, et al. Tissue-engineered heart valve leaflets: Does cell origin affect outcome? Circulation 1997;96(9 Suppl.):II-102-II-107
21. Sodian R, Hoerstrup SP, Sperling JS, et al. Early in vivo experience with tissue-engineered trileaflet heart valves. Circulation 2000;102:III-22-III-29
22. Stock UA, Nagashima M, Khalil PN, et al. Tissue-engineered valved conduits in the pulmonary circulation. J Thorac Cardiovasc Surg 2000;119:732-740
23. Hoerstrup SP, Kadner A, Melnitchouk S, et al. Tissue engineering of a functional trileaflet heart valves from human marrow stromal cells. Circulation 2002;106(Suppl.I):I-143-I-150
24. Steinhoff G, Stock U, Karim N, et al. Tissue engineering of pulmonary heart valves on allogenic acellular matrix conduits: In vivo restoration of valve tissue. Circulation 2000;102(Suppl.3):III-50-III-55
25. Schmidt C, Baier JM. Acellular vascular tissues: Natural biomaterials for tissue repair and tissue engineering. Biomaterials 2000;21:2215-2231
26. Dohmen PM, Lembcke A, Hotz H, Kivelitz D, Konertz WF. Ross operation with a tissue-engineered heart valve. Ann Thorac Surg 2002;74:1438-1442
27. Cebotari S, Mertsching H, Kallenbach K, et al. Construction of autologous human heart valve based on an acellular allograft matrix. Circulation 2002;106(Suppl.I):I-63-I-68
28. Nishi C, Nakajima N, Ikada Y. In vitro evaluation of cytotoxicity of diepoxy compounds used for biomaterial modification. J Biomed Mater Res 1995;29:829-834
29. Augustin C, Damour O. Pharmacotoxicological applications of an equivalent dermis: Three measurements of cytotoxicity. Cell Biol Toxicol 1995;11:167-171
30. Samouillan V, Dandurand-lods J, Lamure A, et al. Thermal analysis characterization of aortic tissues for cardiac valve bioprostheses. J Biomed Mater Res 1999;46:531-538